Charcot‐marie‐tooth disease: a clinico‐genetic confrontation N Barisic, KG Claeys, M Sirotković‐Skerlev, A Löfgren, E Nelis, ... Annals of human genetics 72 (3), 416-441, 2008 | 202 | 2008 |
Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters M Sirotkovic-Skerlev, S Krizanac, S Kapitanovic, K Husnjak, J Unusic, ... Experimental and molecular pathology 79 (1), 42-50, 2005 | 66 | 2005 |
Human Papillomavirus Male Genital Infection: Clinical Variations and the Significance of DNA Typing M Skerlev, M Grce, M Sirotkovic-Skerlev, K Husnjak, J Lipozencic Clinics in Dermatology 20, 173-178, 2002 | 38 | 2002 |
TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions M Sirotkovic-Skerlev, T Cacev, S Krizanac, A Kulić, K Pavelic, ... Experimental and molecular pathology 83 (1), 54-58, 2007 | 35 | 2007 |
Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients A Kulić, M Sirotković-Skerlev, S Jelisavac-Ćosić, D Herceg, Z Kovač, ... Medical oncology 27, 887-893, 2010 | 34 | 2010 |
Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype A Kulić, ND Plavetić, S Gamulin, J Jakić-Razumović, D Vrbanec, ... Medical Oncology 33, 1-6, 2016 | 32 | 2016 |
In vivo effect of progesteron and estrogen on thymus mass and T-cell functions in female mice T Marotti, M Sirotković, J Pavelić, J Gabrilovac, K Pavelić Hormone and metabolic research 16 (04), 201-203, 1984 | 32 | 1984 |
Mitochondrial unfolded protein response, mitophagy and other mitochondrial quality control mechanisms in heart disease and aged heart T Svaguša, M Martinić, M Martinić, L Kovačević, A Šepac, D Miličić, ... Croatian medical journal 61 (3), 126-138, 2020 | 31 | 2020 |
Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma–a 7 … S Jelisavac-Cosic, M Sirotkovic-Skerlev, A Kulic, J Jakic-Razumovic, ... Tumori Journal 97 (4), 532-539, 2011 | 28 | 2011 |
Pathophysiology of ischaemia-reperfusion injury M Sirotković-Skerlev, S Plestina, I Bilić, Z Kovac Lijecnicki vjesnik 128 (3-4), 87-95, 2006 | 27 | 2006 |
Low serum MMP-1 in breast cancer: a negative prognostic factor? A Kulić, N Dedić Plavetić, J Vrbanec, M Sirotković-Skerlev Biomarkers 17 (5), 416-421, 2012 | 17 | 2012 |
Oncogenic aspects of HPV infections of the female genital tract J Zekan, M Sirotkovic-Skerlev, M Skerlev DNA Replication-Current Advances, 2011 | 14 | 2011 |
Prognostic value of circulating Bcl-2 and anti-p53 antibodies in patients with breast cancer: A long term follow-up (17.5 years) M Sirotković-Skerlev, ND Plavetić, F Sedlić, SK Kuna, D Vrbanec, B Belev, ... Cancer Biomarkers 30 (1), 95-104, 2021 | 13 | 2021 |
Mollusca contagiosa: From paediatric dermatology to sexually transmitted infection M Skerlev, K Husar, M Sirotković-Skerlev Der Hautarzt 60, 472-476, 2009 | 13* | 2009 |
Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu … M Barić, A Kulić, M Sirotković-Skerlev, N Dedić Plavetić, M Vidović, ... Pathology & Oncology Research 21, 589-595, 2015 | 11 | 2015 |
Protumor effects of proinflammatory mediators in breast cancer M Sirotković-Skerlev, A Kulić, L Bradić, T Čačev Periodicum biologorum 114 (4), 489-496, 2012 | 11 | 2012 |
Prognostic value of ki-67 in breast carcinoma: tissue microarray method versus whole section analysis-potentials and pitfalls N Dedić Plavetić, J Jakić-Razumović, A Kulić, M Sirotković-Skerlev, ... Pathology & Oncology Research 21, 315-324, 2015 | 9 | 2015 |
Sirtuins in tumorigenesis A Kulić, M Sirotković-Skerlev, N Dedić Plavetić, B Belev, S Kralik-Oguić, ... Periodicum biologorum 116 (4), 381-386, 2014 | 4 | 2014 |
Tumor necrosis factor alpha and breast cancer M Sirotković-Skerlev, T Čačev, S Kapitanović Periodicum biologorum 108 (5), 541-546, 2006 | 4 | 2006 |
Onkogeni aspekti HPV-genitalnih infekcija kod žena J Zekan, M Sirotković-Skerlev, A Ćorušić, J Lešin Medicus 18 (1_Spolno prenosive b), 67-71, 2009 | 3 | 2009 |